Osteoarthritis is a degenerative joint disease which commonly impacts the knees, hands, hips, neck and lower back. This is the first of two stories describing recent progress in understanding the ...

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have created a promising injectable cell therapy to treat osteoarthritis that both reduces inflammation and also regenerates ...

Early symptoms of relapsing polychondritis include sudden pain in cartilage, ear swelling, joint inflammation, and eye problems. Although polychondritis is not currently curable, treatment helps ...

A research team from Northwest University, China, has developed a breakthrough nano-composite hydrogel system to address the dual challenges of inflammation and cartilage damage in osteoarthritis (OA) ...

A new study from Yale University School of Medicine found that inhibition of cytosolic phospholipase A2 (cPLA2), which drives inflammation and chondrocyte aging, preserves cartilage and reduces pain.

The authors note that combining immune regulation with controlled cartilage induction via a biocompatible hydrogel overcomes limitations of traditional OA treatments. The dual-drug delivery system not ...

Joint pain is a widespread issue affecting millions worldwide, from athletes and fitness enthusiasts to aging adults looking to maintain mobility and quality of life. While many over-the-counter ...

A new study found long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat osteoarthritis of the knee may worsen inflammation. The research found joint inflammation and cartilage ...

A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support ...

In today’s world, maintaining joint health is more critical than ever. With increasing sedentary lifestyles and higher stress levels, individuals are more prone to joint discomfort and mobility issues ...